BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17937829)

  • 1. Coverage with evidence development: an examination of conceptual and policy issues.
    Hutton J; Trueman P; Henshall C
    Int J Technol Assess Health Care; 2007; 23(4):425-32. PubMed ID: 17937829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coverage with Evidence Development: applications and issues.
    Trueman P; Grainger DL; Downs KE
    Int J Technol Assess Health Care; 2010 Jan; 26(1):79-85. PubMed ID: 20059784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coverage with evidence development: the Ontario experience.
    Levin L; Goeree R; Levine M; Krahn M; Easty T; Brown A; Henry D
    Int J Technol Assess Health Care; 2011 Apr; 27(2):159-68. PubMed ID: 21473814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coverage with evidence development: a very good beginning, but much to be done. Commentary to Hutton et al.
    Tunis SR; Chalkidou K
    Int J Technol Assess Health Care; 2007; 23(4):432-5. PubMed ID: 17937830
    [No Abstract]   [Full Text] [Related]  

  • 5. Coverage with evidence development for pharmaceuticals: a policy in evolution?
    Lexchin J
    Int J Health Serv; 2011; 41(2):337-54. PubMed ID: 21563627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Politics and its intersection with coverage with evidence development: a qualitative analysis from expert interviews.
    Bishop D; Lexchin J
    BMC Health Serv Res; 2013 Mar; 13():88. PubMed ID: 23497271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding the scientific basis of health technology assessment: a research agenda for the next decade.
    Battista RN
    Int J Technol Assess Health Care; 2006; 22(3):275-80; discussion 280-2. PubMed ID: 16984053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new NICE Evaluation Pathway for medical technologies.
    Campbell B
    Ann R Coll Surg Engl; 2010 Jul; 92(5):435-6. PubMed ID: 20653073
    [No Abstract]   [Full Text] [Related]  

  • 9. An Ethical Analysis of Coverage With Evidence Development.
    Carter D; Merlin T; Hunter D
    Value Health; 2019 Aug; 22(8):878-883. PubMed ID: 31426928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasty or nice? A perspective on the use of health technology assessment in the United Kingdom.
    Drummond M; Sorenson C
    Value Health; 2009 Jun; 12 Suppl 2():S8-13. PubMed ID: 19523188
    [No Abstract]   [Full Text] [Related]  

  • 11. Public engagement in health technology assessment and coverage decisions: a study of experiences in France, Germany, and the United Kingdom.
    Kreis J; Schmidt H
    J Health Polit Policy Law; 2013 Feb; 38(1):89-122. PubMed ID: 23052686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction of emerging medical devices on the market: a new procedure in Belgium.
    Vinck I; Neyt M; Thiry N; Louagie M; Ramaekers D
    Int J Technol Assess Health Care; 2007; 23(4):449-54. PubMed ID: 17937833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coverage with evidence development: ethical issues and policy implications.
    Miller FG; Pearson SD
    Med Care; 2008 Jul; 46(7):746-51. PubMed ID: 18580395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coverage options for promising technologies: Medicare's 'coverage with evidence development'.
    Tunis SR; Pearson SD
    Health Aff (Millwood); 2006; 25(5):1218-30. PubMed ID: 16966717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health technology assessment in policy and practice. Working group 6 report.
    von Below GC; Boer A; Conde-Olasagasti JL; Dillon A; Gibis B; Grilli R; Hardy C; Liaropoulos L; Martín-Moreno JM; Roine R; Scherstén T; Søreide O; Züllig M
    Int J Technol Assess Health Care; 2002; 18(2):447-55. PubMed ID: 12053429
    [No Abstract]   [Full Text] [Related]  

  • 16. Uncertainty and Coverage With Evidence Development: Does Practice Meet Theory?
    Pouwels XGLV; Grutters JPC; Bindels J; Ramaekers BLT; Joore MA
    Value Health; 2019 Jul; 22(7):799-807. PubMed ID: 31277827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mobilising modern facts: health technology assessment and the politics of evidence.
    May C
    Sociol Health Illn; 2006 Jul; 28(5):513-32. PubMed ID: 16910945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of coverage with evidence development schemes for medical devices: A decision tool for late technology adopter countries.
    Kovács S; Kaló Z; Daubner-Bendes R; Kolasa K; Hren R; Tesar T; Reckers-Droog V; Brouwer W; Federici C; Drummond M; Zemplényi AT
    Health Econ; 2022 Sep; 31 Suppl 1(Suppl 1):195-206. PubMed ID: 35322478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementing evidence-based medicine through medicare coverage decisions.
    Foote SB; Town RJ
    Health Aff (Millwood); 2007; 26(6):1634-42. PubMed ID: 17978383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health technology assessment in Switzerland: a descriptive analysis of "Coverage with Evidence Development" decisions from 1996 to 2013.
    Brügger U; Horisberger B; Ruckstuhl A; Plessow R; Eichler K; Gratwohl A
    BMJ Open; 2015 Mar; 5(3):e007021. PubMed ID: 25818273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.